Health Care Equipment & Services

Insider selling by Intuitive Surgical’s SVP shows routine, Rule 10b5‑1‑planned trades, while European distribution gains and strong clinical data keep investors confident in steady growth.

Teleflex CFO’s 400% jump in shares signals strong insider confidence in its growth strategy, hinting at a possible upside for investors.

Medtronic CFO Thierry Piéton’s recent share sale signals routine portfolio rebalancing amid market dips, but investors should watch insider trends and the GE HealthCare partnership for future moves.

ClearPoint Neuro insider moves reveal long‑term confidence amid a 36 % stock slide—insights on RSU activity, liquidity tactics, and future strategy.

Insider buys reveal VSee Health’s confidence in a turnaround and GoMyRx partnership – could the low‑priced stock rebound?

ClearPoint Neuro insider buys signal confidence: COO’s March 2026 trade shows strategic buying as stock dips, hinting at a potential rebound.

Wampler Kira Scherer’s insider buy of 2,000 Doximity shares signals confidence in the health‑tech platform’s security, growth prospects, and regulatory readiness—insights for clinicians and investors alike.

Insider sale by Clover Health CEO signals cautious outlook; analyze share price impact, investor sentiment, and long‑term prospects for informed decisions.

RadNet’s $270 M AI‑radiology deal powers a cloud‑first future, boosting breast‑cancer detection by 12% and cutting false positives—CEO’s share buy confirms confidence and may steady investors amid regulatory and earnings challenges.

ResMed insider sale: 2,000 shares sold at $260.22 on March 4, 2026 – a routine, rule‑based liquidity move that won’t sway the stock, with the company’s solid fundamentals and sleep‑care growth outlook intact.